Larimar Therapeutics (LRMR) Short Interest Ratio & Short Volume → Do This Today BEFORE Biden Wins in November (From Stansberry Research) (Ad) Free LRMR Stock Alerts $7.22 -0.64 (-8.14%) (As of 03:34 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Larimar Therapeutics Short Interest DataCurrent Short Volume3,900,000 sharesPrevious Short Volume3,630,000 sharesChange Vs. Previous Month+7.44%Dollar Volume Sold Short$26.87 millionShort Interest Ratio / Days to Cover6.1Last Record DateApril 30, 2024Outstanding Shares63,800,000 sharesPercentage of Shares Shorted6.11%Today's Trading Volume258,512 sharesAverage Trading Volume517,008 sharesToday's Volume Vs. Average50% Short Selling Larimar Therapeutics ? Sign up to receive the latest short interest report for Larimar Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLRMR Short Interest Over TimeLRMR Days to Cover Over TimeLRMR Percentage of Float Shorted Over Time Ad Stansberry ResearchDo This Today BEFORE Biden Wins in NovemberDiscover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).Find out how you can too in this free video. Larimar Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,900,000 shares $26.87 million +7.4%N/A6.1 $6.89 4/15/20243,630,000 shares $26.50 million +13.8%N/A5.8 $7.30 3/31/20243,190,000 shares $24.21 million +95.7%N/A5.5 $7.59 3/15/20241,630,000 shares $14.18 million +221.6%N/A2.9 $8.70 2/29/2024506,800 shares $5.83 million -18.0%N/A1.1 $11.50 2/15/2024618,200 shares $8.21 million +82.0%3.5%1.5 $13.28 Get the Latest News and Ratings for LRMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Larimar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024339,700 shares $1.97 million -4.9%N/A2.2 $5.79 1/15/2024357,100 shares $1.65 million -8.4%N/A2.8 $4.61 12/31/2023390,000 shares $1.77 million -4.0%N/A3 $4.55 12/15/2023406,100 shares $1.71 million -16.5%N/A4.1 $4.22 11/30/2023486,400 shares $1.67 million -7.8%N/A4.6 $3.43 11/15/2023527,400 shares $1.55 million -8.6%N/A4.8 $2.93 10/31/2023576,900 shares $1.69 million +0.2%N/A4.9 $2.93 10/15/2023575,600 shares $1.69 million -11.3%N/A2.7 $2.93 9/30/2023648,700 shares $2.56 million +7.9%N/A3.2 $3.95 9/15/2023601,100 shares $2.55 million -5.1%N/A2.9 $4.24 8/31/2023633,200 shares $2.36 million +9.9%N/A2.3 $3.72 8/15/2023576,200 shares $2.41 million -12.9%N/A2 $4.18 7/31/2023661,800 shares $2.83 million +3.8%N/A1.8 $4.28 7/15/2023637,500 shares $2.05 million +7.3%N/A2.3 $3.21 6/30/2023594,100 shares $1.86 million +296.3%N/A2.1 $3.13 6/15/2023149,900 shares $509,660.00 -23.9%N/A0.5 $3.40 5/31/2023197,000 shares $726,930.00 -12.0%N/A0.8 $3.69 5/15/2023223,800 shares $803,442.00 -14.3%N/A0.8 $3.59 4/30/2023261,000 shares $1.23 million -14.1%N/A1.2 $4.73 4/15/2023303,700 shares $1.38 million -1.2%N/A1.4 $4.53 3/31/2023307,500 shares $1.39 million -12.4%N/A1.5 $4.53 3/15/2023350,900 shares $2.03 million +3.0%N/A2 $5.79 2/28/2023340,600 shares $2.06 million +43.3%N/A1.9 $6.06 2/15/2023237,700 shares $1.41 million -6.2%N/A1.6 $5.93 1/31/2023253,300 shares $1.25 million -0.2%N/A2.2 $4.94 1/15/2023253,900 shares $1.18 million -1.1%N/A2.4 $4.65 12/30/2022256,800 shares $1.06 million -25.4%N/A2.4 $4.13 12/15/2022344,300 shares $1.57 million -9.7%N/A3 $4.56 11/30/2022381,300 shares $1.21 million +2.3%N/A2.2 $3.17 11/15/2022372,800 shares $1.13 million +12.5%N/A2.1 $3.03 10/31/2022331,500 shares $1.09 million +4.5%N/A1 $3.30 10/15/2022317,300 shares $970,938.00 -2.9%N/A1 $3.06 9/30/2022326,700 shares $1.05 million +17.8%N/A1 $3.20 9/15/2022277,300 shares $934,501.00 +2.0%1.6%0.9 $3.37Do This Today BEFORE Biden Wins in November (Ad)Discover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).Find out how you can too in this free video. LRMR Short Interest - Frequently Asked Questions What is Larimar Therapeutics' current short interest? Short interest is the volume of Larimar Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 3,900,000 shares of LRMR short. Learn More on Larimar Therapeutics' current short interest. What is a good short interest ratio for Larimar Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LRMR shares currently have a short interest ratio of 6.0. Learn More on Larimar Therapeutics's short interest ratio. Which institutional investors are shorting Larimar Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Larimar Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Larimar Therapeutics' short interest increasing or decreasing? Larimar Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 3,900,000 shares, an increase of 7.4% from the previous total of 3,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Larimar Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Larimar Therapeutics: Verve Therapeutics, Inc. (30.19%), Altimmune, Inc. (31.47%), KalVista Pharmaceuticals, Inc. (13.13%), Travere Therapeutics, Inc. (16.83%), Oculis Holding AG (0.20%), Shattuck Labs, Inc. (4.29%), COMPASS Pathways plc (5.51%), Arbutus Biopharma Co. (3.08%), Adlai Nortye Ltd. (0.03%), Astria Therapeutics, Inc. (10.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Larimar Therapeutics stock? Short selling LRMR is an investing strategy that aims to generate trading profit from Larimar Therapeutics as its price is falling. LRMR shares are trading down $0.64 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Larimar Therapeutics? A short squeeze for Larimar Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LRMR, which in turn drives the price of the stock up even further. How often is Larimar Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LRMR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: VERV Short Interest Data ALT Short Interest Data KALV Short Interest Data TVTX Short Interest Data OCS Short Interest Data STTK Short Interest Data CMPS Short Interest Data ABUS Short Interest Data ANL Short Interest Data ATXS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LRMR) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis 1 Biotech Stock has been shocking the marketsHuge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe Exchange